We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLVX
2601
DELISTED
HilleVax
HLVX
| $364K | ﹤0.01% |
21,778
+3,624
| +20% | +$65.4K |
|
|
KBAL
2602
DELISTED
Kimball International
KBAL
| $364K | ﹤0.01% |
56,063
+420
| +0.8% | +$2.87K |
|
2603
Ocugen
OCGN
$434M
| $361K | ﹤0.01% |
277,897
+9,578
| +4% | +$14.9K |
|
2604
SmartRent
SMRT
$272M
| $358K | ﹤0.01% |
147,335
+3,618
| +3% | +$8.95K |
|
|
PCSB
2605
DELISTED
PCSB Financial Corporation
PCSB
| $356K | ﹤0.01% |
18,720
-255
| -1% | -$4.91K |
|
2606
American Public Education
APEI
$940M
| $354K | ﹤0.01% |
28,837
-639
| -2% | -$7.92K |
|
2607
BayCom
BCML
$333M
| $353K | ﹤0.01% |
18,580
-206
| -1% | -$3.87K |
|
2608
Microvast
MVST
$302M
| $353K | ﹤0.01% |
230,744
+3,391
| +1% | +$6.91K |
|
2609
Digimarc Corp
DMRC
$178M
| $352K | ﹤0.01% |
19,054
+217
| +1% | +$4.05K |
|
2610
5E Advanced Materials
FEAM
$62.3M
| $352K | ﹤0.01% |
1,944
+187
| +11% | +$46.1K |
|
2611
Third Coast Bancshares
TCBX
$738M
| $351K | ﹤0.01% |
19,044
+47
| +0.2% | +$871 |
|
2612
Definitive Healthcare
DH
$75.3M
| $349K | ﹤0.01% |
31,731
-2,576
| -8% | -$33.1K |
|
2613
Vera Therapeutics
VERA
$2.36B
| $349K | ﹤0.01% |
18,053
+453
| +3% | +$8.2K |
|
2614
Arbutus Biopharma
ABUS
$915M
| $348K | ﹤0.01% |
149,535
+6,695
| +5% | +$16K |
|
2615
Colony Bankcorp
CBAN
$467M
| $347K | ﹤0.01% |
27,342
+886
| +3% | +$11.9K |
|
2616
iShares US Treasury Bond ETF
GOVT
$43.6B
| $346K | ﹤0.01% |
15,238
| – | – |
|
2617
Red River Bancshares
RRBI
$659M
| $346K | ﹤0.01% |
6,775
-41
| -0.6% | -$2.23K |
|
2618
Phathom Pharmaceuticals
PHAT
$692M
| $345K | ﹤0.01% |
30,732
+1,805
| +6% | +$18.6K |
|
2619
UWM Holdings
UWMC
$434M
| $344K | ﹤0.01% |
103,916
+3,023
| +3% | +$11.3K |
|
|
TSP
2620
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $344K | ﹤0.01% |
209,954
-297
| -0.1% | -$1.06K |
|
2621
Telos
TLS
$358M
| $343K | ﹤0.01% |
67,314
+1,140
| +2% | +$7.54K |
|
2622
Donegal Group Class A
DGICA
$714M
| $342K | ﹤0.01% |
24,074
+367
| +2% | +$5.33K |
|
|
TRUE
2623
DELISTED
TrueCar
TRUE
| $342K | ﹤0.01% |
136,292
-1,234
| -0.9% | -$2.57K |
|
|
NETI
2624
DELISTED
Eneti Inc.
NETI
| $342K | ﹤0.01% |
33,993
+814
| +2% | +$7.22K |
|
|
CTLP
2625
DELISTED
Cantaloupe
CTLP
| $341K | ﹤0.01% |
78,390
+1,130
| +1% | +$4.01K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.